In NSCLC BM, one study observed high levels of TROP2 expression at the RNA level that are ubiquitously present in resected BM of NSCLC patients, but no matched nor unmatched primary tumors were described as controls [117]. Here, TACSTD2 is linked to non-small cell lung carcinoma.